Tumor stromal phenotypes define VEGF sensitivity--response.

Smith, Neil R; Baker, Dawn; Farren, Matthew; Pommier, Aurelien; Swann, Ruth; Wang, Xin; Mistry, Sunita; McDaid, Karen; Kendrew, Jane; Womack, Chris; Wedge, Stephen R; Barry, Simon T

Smith, Neil R; Baker, Dawn; Farren, Matthew; Pommier, Aurelien; Swann, Ruth; Wang, Xin; Mistry, Sunita; McDaid, Karen; Kendrew, Jane; Womack, Chris; Wedge, Stephen R; Barry, Simon T.

Afiliación

Smith NR; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom. neil.n.r.smith@astrazeneca.com simon.t.barry@astrazeneca.com.
Baker D; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Farren M; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Pommier A; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Swann R; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Wang X; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Mistry S; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
McDaid K; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Kendrew J; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Womack C; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom.
Wedge SR; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
Barry ST; Oncology Innovative Medicines, AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom. neil.n.r.smith@astrazeneca.com simon.t.barry@astrazeneca.com.

Clin Cancer Res ; 20(19): 5141, 2014 Oct 01.

Article en En | MEDLINE | ID: mdl-25274380

Asunto(s)

Anticuerpos Monoclonales Humanizados/administración & dosificación; Neoplasias/genética; Células del Estroma/metabolismo; Factor A de Crecimiento Endotelial Vascular/genética; Humanos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células del Estroma / Factor A de Crecimiento Endotelial Vascular / Anticuerpos Monoclonales Humanizados / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google